Skip to main content

Presidential Plenary Session

Description

Meyer-Rokitansky-Kustner-Hauser Syndrome - A Non-lethal Birth Defect with Broad Implications for Health Care - Featuring the Presentation of the 2020 ACMG Foundation Awards

This session will expose the participant to one indication for a temporary organ transplantation to manage a non-lethal birth defect, Mayer –Rokitansky-Kuster-Hauser syndrome. This condition is not associated with an obvious physical impairment or disfigurement. Attendees will better appreciate that although not obvious this condition has a significant impact on the lives of those affected and their families. This session explores the scientific advances and the ethical controversies that surround – the use of a high tech risky intervention to manage a non-lethal birth defect associated with no obvious physical impairment.

Contributors

  • Anthony R. Gregg, MD, MBA, FACMG.

    During his previous two years as president elect, Dr. Gregg served on several committees of the ACMG Board of Directors and ACMG Foundation Board, participated on several practice guideline work groups, and served as liaison between ACMG and the American College of Obstetricians and Gynecologists, a post he has held since 2013. He was also invited before Congress in 2017 to give expert briefing on advances in prenatal genetic screening on behalf of ACMG. His earlier involvement with ACMG includes serving on the Board of Directors from 2009–2015, as Clinical Vice President from 2013–2015, and as a member of the Practice Guidelines Committee from 2013–2015. Recognized as one of the Best Doctors in America for 2017–2018, Dr. Gregg currently holds positions as Chair of the Department of Obstetrics and Gynecology and Chief of Maternal Fetal Medicine at Baylor University Medical Center. Previously at the University of Florida College of Medicine, where he was recognized for exemplary teaching, Dr. Gregg was Director of Maternal Fetal Medicine and the Maternal-Fetal Medicine Fellowship Program from 2011–2017 as well as the Director of Obstetrics at Shands Hospital. Dr. Gregg’s principal research interests relate to high-risk obstetrics. He participated as an investigator on numerous clinical trials and was supported by the National Institutes of Health to evaluate a mouse model of hypertension in pregnancy during his time as an associate professor at the University of South Carolina School of Medicine, from 2004–2011. He has also served as a reviewer on multiple special emphasis panels for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), including five years as chair of the advisory board for the institute’s Genomics and Proteomics Network for Preterm Birth Research. Dr. Gregg studied biology as an undergraduate at Loyola University of Chicago and earned his medical degree at Loyola University Stritch School of Medicine. He completed his residency in obstetrics and gynecology at Loyola University Foster McGaw Hospital, his fellowship in maternal-fetal medicine at the University of Iowa Hospitals and Clinics, and his postdoctoral fellowship in medical genetics at Baylor College of Medicine.

  • Liza Johannesson, MD, PhD.

    Dr Liza Johannesson (MD PhD) specializes in obstetrics and gynecology with a special interest in gynecologic oncology and transplantation. She graduated from the Nobel Prize awarding Karolinska Institute in Stockholm, Sweden. Her residency in obstetrics and gynecology was completed at the Sahlgrenska University Hospital in Gothenburg, Sweden, followed by fellowships in gynecologic oncology at Sahlgrenska University Hospital and Royal Adelaide Hospital, Adelaide, Australia. She started performing research in 2009 on Uterus Transplantation and presented her thesis in 2012. She was a pivotal part of the world pioneering first clinical human trial of Uterus Transplantation that started in Sweden 2012 and so far resulted in 9 live births. Since 2016 she is the Medical Director of Uterus Transplantation at Baylor University Medical Center in Dallas which is currently the largest Uterus Transplant program in the world. She is an assistant professor of Surgery at Texas A&M. She is president elect of the U.S. Uterus Transplant Consortium (USUTC) and serves in the Vascular Composite Allograft (VCA) committee for American Society of Transplant Surgery (ASTS).

  • Ann Marie Warren, PhD.

    Ann Marie Warren, PhD, ABPP, is a licensed psychologist and Co-Director of the Trauma Research at Baylor University Medical Center, part of Baylor Scott & White Health. She is also the Director of Neuropsychology and Rehabilitation Psychology for Baylor Scott & White Health Institute for Rehabilitation. She is also a Clinical Assistant Professor at Texas A&M in the Department of Surgery. As both a treating psychologist and clinical researcher with over 18 years of experience at Baylor University Medical Center and Baylor Scott & White Institute for Rehabilitation, her work has focused primarily on the psychological aspects of traumatic physical injury. More recently, she has been involved as a co-investigator with the Uterine Transplant Clinical Trial at Baylor University Medical Center, and has published some of the initial data on the psychological factors including the first paper published on altruistic donors. She received a PhD from the University of North Texas and is Board Certified in rehabilitation psychology by the American Board of Professional Psychology. She has been the principal investigator of several funded research projects and multi-site collaborations pertaining to the psychological aspects of injury and illness, including depression, posttraumatic stress and resilience. Dr. Warren is a frequent lecturer at both regional and national conferences and has been frequently published in both surgical and psychological peer reviewed journals.

March 18, 2020
Wed 10:00 AM CDT

Duration 2H 0M

Already Registered?